Skip to content

Randomized Controlled Trial of Subcuticular Skin Closure Versus Steri-strip S Closure

Closing Linear Incisions in Plastic Surgery: A Randomized Clinical Trial Comparing a New Coaptive Film Device Versus Standard Subcuticular Sutures for Scar Quality, Patient Comfort, and Closure Time

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00727025
Enrollment
51
Registered
2008-08-01
Start date
2005-07-31
Completion date
2008-03-31
Last updated
2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Elastosis, Breast Hypertrophy, Breast Reconstruction

Keywords

skin closure devices, linear scars

Brief summary

Purpose: The aims of this randomized clinical trial are: 1. to assess scar quality from the patient and surgeon perspectives 2. to assess patient comfort in the days immediately following surgery 3. to assess the time taken to complete closure in the operating room. 4. the financial benefit or cost for the institution of using Steri Strip S will also be estimated. Two closure methods will be compared, a new coaptive film device (Steri Strip S) versus standard subcuticular sutures. The linear incisions will include the standard incision segments utilized for an inverted-T closure for bilateral breast reduction and the transabdominal incision segments utilized for abdominoplasty or TRAM flap harvest. Our hypothesis is that incisions segments closed with Steri Strip S compared to standard subcuticular closure, will yield scars of better cosmetic quality, in shorter time to closure, with novice and expert surgeons, for both bilateral breast reduction and abdominoplasty surgical procedures.

Interventions

DEVICEwound closure device (Steri-Strip™)

wound closure with steri-strip S

Sponsors

Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients are eligible for enrollment if they agree to provide informed consent, are at least 18 years of age, in generally good health, and available for follow-up in the 5-7 month time frame.

Exclusion criteria

* Women known to be pregnant, minors, patients potentially incompetent to provide informed consent or complete the surveys described in our protocol will be excluded from this trial.

Design outcomes

Primary

MeasureTime frameDescription
Scar Quality at 6 Months Postoperative6 monthsPatients used a rating scale with range of 1-9 with 1 being the best scar and 9 being the worst scar. Patients had photos of scars within this range to anchor their choices.
Time to Perform Wound ClosureintraoperativelyTime from completion of deep dermal closure to complete closure of wound, either by steri-strip application or by subcuticular suture

Secondary

MeasureTime frameDescription
Patient Postoperative Incisional Comfort10 daysUsing a comfort scale from 0-10 with 0 being very uncomfortable and 10 being very comfortable

Countries

United States

Participant flow

Recruitment details

all woman undergoing bilateral breast reduction using the Wise pattern approach. Pts were recruited between Feb 2006 and Sept 2007

Pre-assignment details

Patients declined

Participants by arm

ArmCount
All Participants
Participants randomized to have one segment of wounds closed with steri-strip device and the other wound segment closed with traditional suture closure.
74
Total74

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyPhysician Decision23

Baseline characteristics

CharacteristicAll Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
74 Participants
Age, Continuous47 years
STANDARD_DEVIATION 5.6
Region of Enrollment
United States
74 participants
Sex: Female, Male
Female
74 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 740 / 74
serious
Total, serious adverse events
0 / 740 / 74

Outcome results

Primary

Scar Quality at 6 Months Postoperative

Patients used a rating scale with range of 1-9 with 1 being the best scar and 9 being the worst scar. Patients had photos of scars within this range to anchor their choices.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
Wounds Closed With DeviceScar Quality at 6 Months Postoperative3.8 units on a scaleStandard Deviation 2.9
Wounds Closed With SutureScar Quality at 6 Months Postoperative2.6 units on a scaleStandard Deviation 2.1
Primary

Time to Perform Wound Closure

Time from completion of deep dermal closure to complete closure of wound, either by steri-strip application or by subcuticular suture

Time frame: intraoperatively

Population: those who completed application of devices intraoperatively

ArmMeasureValue (MEAN)Dispersion
Wounds Closed With DeviceTime to Perform Wound Closure2.0 minutesStandard Deviation 1.1
Wounds Closed With SutureTime to Perform Wound Closure4.6 minutesStandard Deviation 1.6
Secondary

Patient Postoperative Incisional Comfort

Using a comfort scale from 0-10 with 0 being very uncomfortable and 10 being very comfortable

Time frame: 10 days

ArmMeasureValue (MEAN)Dispersion
Wounds Closed With DevicePatient Postoperative Incisional Comfort5.8 units on a scaleStandard Deviation 2.7
Wounds Closed With SuturePatient Postoperative Incisional Comfort6.9 units on a scaleStandard Deviation 2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026